img

Global Oral Vaccine for Human Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Oral Vaccine for Human Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Orally administered vaccines are of interest, as they elicit both systemic and mucosal immunities, in which mucosal immunity would neutralize the mucosa invading pathogen before the onset of an infection. 
Oral Vaccine for Human report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Oral Vaccine for Human market is projected to reach US$ 3746.5 million in 2029, increasing from US$ 2540 million in 2022, with the CAGR of 5.7% during the period of 2024 to 2029. Demand from Public and Private are the major drivers for the industry.
The oral vaccine market is driven by the growing demand for convenient and needle-free vaccination options, especially in pediatric and developing regions. Oral vaccines offer advantages like ease of administration, increased patient compliance, and simplified logistics, making them suitable for mass vaccination programs and reaching remote areas with limited healthcare infrastructure. The potential for improved vaccine stability and reduced production costs further contribute to market growth. However, the market also faces challenges, such as the need for enhanced vaccine stability to withstand gastrointestinal conditions and ensuring consistent efficacy across diverse populations. Additionally, regulatory complexities and the requirement for stringent safety and efficacy data can pose obstacles for oral vaccine manufacturers. To succeed in this market, companies must focus on innovative vaccine delivery technologies, conduct robust clinical trials, collaborate with global health agencies, and address public perception and trust in oral vaccine safety and effectiveness.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Oral Vaccine for Human market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Segment by Type
Rotavirus Vaccine
Cholera Vaccine
Oral Polio Vaccine
Other

Segment by Application


Public
Private

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Oral Vaccine for Human market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Oral Vaccine for Human, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Oral Vaccine for Human industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Oral Vaccine for Human in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Oral Vaccine for Human introduction, etc. Oral Vaccine for Human Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Oral Vaccine for Human market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Oral Vaccine for Human Market Overview
1.1 Oral Vaccine for Human Product Overview
1.2 Oral Vaccine for Human Market Segment by Type
1.2.1 Rotavirus Vaccine
1.2.2 Cholera Vaccine
1.2.3 Oral Polio Vaccine
1.2.4 Other
1.3 Global Oral Vaccine for Human Market Size by Type
1.3.1 Global Oral Vaccine for Human Market Size Overview by Type (2018-2029)
1.3.2 Global Oral Vaccine for Human Historic Market Size Review by Type (2018-2024)
1.3.3 Global Oral Vaccine for Human Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Oral Vaccine for Human Sales Breakdown by Type (2018-2024)
1.4.2 Europe Oral Vaccine for Human Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Oral Vaccine for Human Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Oral Vaccine for Human Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Oral Vaccine for Human Sales Breakdown by Type (2018-2024)
2 Global Oral Vaccine for Human Market Competition by Company
2.1 Global Top Players by Oral Vaccine for Human Sales (2018-2024)
2.2 Global Top Players by Oral Vaccine for Human Revenue (2018-2024)
2.3 Global Top Players by Oral Vaccine for Human Price (2018-2024)
2.4 Global Top Manufacturers Oral Vaccine for Human Manufacturing Base Distribution, Sales Area, Product Type
2.5 Oral Vaccine for Human Market Competitive Situation and Trends
2.5.1 Oral Vaccine for Human Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Oral Vaccine for Human Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oral Vaccine for Human as of 2022)
2.7 Date of Key Manufacturers Enter into Oral Vaccine for Human Market
2.8 Key Manufacturers Oral Vaccine for Human Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Oral Vaccine for Human Status and Outlook by Region
3.1 Global Oral Vaccine for Human Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Oral Vaccine for Human Historic Market Size by Region
3.2.1 Global Oral Vaccine for Human Sales in Volume by Region (2018-2024)
3.2.2 Global Oral Vaccine for Human Sales in Value by Region (2018-2024)
3.2.3 Global Oral Vaccine for Human Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Oral Vaccine for Human Forecasted Market Size by Region
3.3.1 Global Oral Vaccine for Human Sales in Volume by Region (2024-2029)
3.3.2 Global Oral Vaccine for Human Sales in Value by Region (2024-2029)
3.3.3 Global Oral Vaccine for Human Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Oral Vaccine for Human by Application
4.1 Oral Vaccine for Human Market Segment by Application
4.1.1 Public
4.1.2 Private
4.2 Global Oral Vaccine for Human Market Size by Application
4.2.1 Global Oral Vaccine for Human Market Size Overview by Application (2018-2029)
4.2.2 Global Oral Vaccine for Human Historic Market Size Review by Application (2018-2024)
4.2.3 Global Oral Vaccine for Human Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Oral Vaccine for Human Sales Breakdown by Application (2018-2024)
4.3.2 Europe Oral Vaccine for Human Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Oral Vaccine for Human Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Oral Vaccine for Human Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Oral Vaccine for Human Sales Breakdown by Application (2018-2024)
5 North America Oral Vaccine for Human by Country
5.1 North America Oral Vaccine for Human Historic Market Size by Country
5.1.1 North America Oral Vaccine for Human Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Oral Vaccine for Human Sales in Volume by Country (2018-2024)
5.1.3 North America Oral Vaccine for Human Sales in Value by Country (2018-2024)
5.2 North America Oral Vaccine for Human Forecasted Market Size by Country
5.2.1 North America Oral Vaccine for Human Sales in Volume by Country (2024-2029)
5.2.2 North America Oral Vaccine for Human Sales in Value by Country (2024-2029)
6 Europe Oral Vaccine for Human by Country
6.1 Europe Oral Vaccine for Human Historic Market Size by Country
6.1.1 Europe Oral Vaccine for Human Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Oral Vaccine for Human Sales in Volume by Country (2018-2024)
6.1.3 Europe Oral Vaccine for Human Sales in Value by Country (2018-2024)
6.2 Europe Oral Vaccine for Human Forecasted Market Size by Country
6.2.1 Europe Oral Vaccine for Human Sales in Volume by Country (2024-2029)
6.2.2 Europe Oral Vaccine for Human Sales in Value by Country (2024-2029)
7 Asia-Pacific Oral Vaccine for Human by Region
7.1 Asia-Pacific Oral Vaccine for Human Historic Market Size by Region
7.1.1 Asia-Pacific Oral Vaccine for Human Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Oral Vaccine for Human Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Oral Vaccine for Human Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Oral Vaccine for Human Forecasted Market Size by Region
7.2.1 Asia-Pacific Oral Vaccine for Human Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Oral Vaccine for Human Sales in Value by Region (2024-2029)
8 Latin America Oral Vaccine for Human by Country
8.1 Latin America Oral Vaccine for Human Historic Market Size by Country
8.1.1 Latin America Oral Vaccine for Human Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Oral Vaccine for Human Sales in Volume by Country (2018-2024)
8.1.3 Latin America Oral Vaccine for Human Sales in Value by Country (2018-2024)
8.2 Latin America Oral Vaccine for Human Forecasted Market Size by Country
8.2.1 Latin America Oral Vaccine for Human Sales in Volume by Country (2024-2029)
8.2.2 Latin America Oral Vaccine for Human Sales in Value by Country (2024-2029)
9 Middle East and Africa Oral Vaccine for Human by Country
9.1 Middle East and Africa Oral Vaccine for Human Historic Market Size by Country
9.1.1 Middle East and Africa Oral Vaccine for Human Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Oral Vaccine for Human Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Oral Vaccine for Human Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Oral Vaccine for Human Forecasted Market Size by Country
9.2.1 Middle East and Africa Oral Vaccine for Human Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Oral Vaccine for Human Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Merck
10.1.1 Merck Company Information
10.1.2 Merck Introduction and Business Overview
10.1.3 Merck Oral Vaccine for Human Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Merck Oral Vaccine for Human Products Offered
10.1.5 Merck Recent Development
10.2 GSK
10.2.1 GSK Company Information
10.2.2 GSK Introduction and Business Overview
10.2.3 GSK Oral Vaccine for Human Sales, Revenue and Gross Margin (2018-2024)
10.2.4 GSK Oral Vaccine for Human Products Offered
10.2.5 GSK Recent Development
10.3 Sanofi
10.3.1 Sanofi Company Information
10.3.2 Sanofi Introduction and Business Overview
10.3.3 Sanofi Oral Vaccine for Human Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Sanofi Oral Vaccine for Human Products Offered
10.3.5 Sanofi Recent Development
10.4 Lanzhou Institute
10.4.1 Lanzhou Institute Company Information
10.4.2 Lanzhou Institute Introduction and Business Overview
10.4.3 Lanzhou Institute Oral Vaccine for Human Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Lanzhou Institute Oral Vaccine for Human Products Offered
10.4.5 Lanzhou Institute Recent Development
10.5 Serum Institute
10.5.1 Serum Institute Company Information
10.5.2 Serum Institute Introduction and Business Overview
10.5.3 Serum Institute Oral Vaccine for Human Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Serum Institute Oral Vaccine for Human Products Offered
10.5.5 Serum Institute Recent Development
10.6 Valneva
10.6.1 Valneva Company Information
10.6.2 Valneva Introduction and Business Overview
10.6.3 Valneva Oral Vaccine for Human Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Valneva Oral Vaccine for Human Products Offered
10.6.5 Valneva Recent Development
10.7 Shanghai United Cell
10.7.1 Shanghai United Cell Company Information
10.7.2 Shanghai United Cell Introduction and Business Overview
10.7.3 Shanghai United Cell Oral Vaccine for Human Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Shanghai United Cell Oral Vaccine for Human Products Offered
10.7.5 Shanghai United Cell Recent Development
10.8 Bibcol
10.8.1 Bibcol Company Information
10.8.2 Bibcol Introduction and Business Overview
10.8.3 Bibcol Oral Vaccine for Human Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Bibcol Oral Vaccine for Human Products Offered
10.8.5 Bibcol Recent Development
10.9 PaxVax
10.9.1 PaxVax Company Information
10.9.2 PaxVax Introduction and Business Overview
10.9.3 PaxVax Oral Vaccine for Human Sales, Revenue and Gross Margin (2018-2024)
10.9.4 PaxVax Oral Vaccine for Human Products Offered
10.9.5 PaxVax Recent Development
10.10 Vabiotech
10.10.1 Vabiotech Company Information
10.10.2 Vabiotech Introduction and Business Overview
10.10.3 Vabiotech Oral Vaccine for Human Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Vabiotech Oral Vaccine for Human Products Offered
10.10.5 Vabiotech Recent Development
10.11 Tiantan Biological
10.11.1 Tiantan Biological Company Information
10.11.2 Tiantan Biological Introduction and Business Overview
10.11.3 Tiantan Biological Oral Vaccine for Human Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Tiantan Biological Oral Vaccine for Human Products Offered
10.11.5 Tiantan Biological Recent Development
10.12 EuBiologics
10.12.1 EuBiologics Company Information
10.12.2 EuBiologics Introduction and Business Overview
10.12.3 EuBiologics Oral Vaccine for Human Sales, Revenue and Gross Margin (2018-2024)
10.12.4 EuBiologics Oral Vaccine for Human Products Offered
10.12.5 EuBiologics Recent Development
10.13 Panacea Biotec Ltd
10.13.1 Panacea Biotec Ltd Company Information
10.13.2 Panacea Biotec Ltd Introduction and Business Overview
10.13.3 Panacea Biotec Ltd Oral Vaccine for Human Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Panacea Biotec Ltd Oral Vaccine for Human Products Offered
10.13.5 Panacea Biotec Ltd Recent Development
10.14 Bio-Med
10.14.1 Bio-Med Company Information
10.14.2 Bio-Med Introduction and Business Overview
10.14.3 Bio-Med Oral Vaccine for Human Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Bio-Med Oral Vaccine for Human Products Offered
10.14.5 Bio-Med Recent Development
10.15 Halfkin Bio-Pharmaceuticals
10.15.1 Halfkin Bio-Pharmaceuticals Company Information
10.15.2 Halfkin Bio-Pharmaceuticals Introduction and Business Overview
10.15.3 Halfkin Bio-Pharmaceuticals Oral Vaccine for Human Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Halfkin Bio-Pharmaceuticals Oral Vaccine for Human Products Offered
10.15.5 Halfkin Bio-Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Oral Vaccine for Human Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Oral Vaccine for Human Industrial Chain Analysis
11.4 Oral Vaccine for Human Market Dynamics
11.4.1 Oral Vaccine for Human Industry Trends
11.4.2 Oral Vaccine for Human Market Drivers
11.4.3 Oral Vaccine for Human Market Challenges
11.4.4 Oral Vaccine for Human Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Oral Vaccine for Human Distributors
12.3 Oral Vaccine for Human Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Rotavirus Vaccine
Table 2. Major Company of Cholera Vaccine
Table 3. Major Company of Oral Polio Vaccine
Table 4. Major Company of Other
Table 5. Global Oral Vaccine for Human Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Oral Vaccine for Human Sales by Type (2018-2024) & (K Units)
Table 7. Global Oral Vaccine for Human Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Oral Vaccine for Human Sales by Type (2018-2024) & (US& Million)
Table 9. Global Oral Vaccine for Human Market Share in Value by Type (2018-2024)
Table 10. Global Oral Vaccine for Human Price by Type (2018-2024) & (US$/Unit)
Table 11. Global Oral Vaccine for Human Sales by Type (2024-2029) & (K Units)
Table 12. Global Oral Vaccine for Human Sales Market Share in Volume by Type (2024-2029)
Table 13. Global Oral Vaccine for Human Sales by Type (2024-2029) & (US$ Million)
Table 14. Global Oral Vaccine for Human Sales Market Share in Value by Type (2024-2029)
Table 15. Global Oral Vaccine for Human Price by Type (2024-2029) & (US$/Unit)
Table 16. North America Oral Vaccine for Human Sales by Type (2018-2024) & (K Units)
Table 17. North America Oral Vaccine for Human Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Oral Vaccine for Human Sales (K Units) by Type (2018-2024)
Table 19. Europe Oral Vaccine for Human Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Oral Vaccine for Human Sales (K Units) by Type (2018-2024)
Table 21. Asia-Pacific Oral Vaccine for Human Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Oral Vaccine for Human Sales (K Units) by Type (2018-2024)
Table 23. Latin America Oral Vaccine for Human Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Oral Vaccine for Human Sales (K Units) by Type (2018-2024)
Table 25. Middle East and Africa Oral Vaccine for Human Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Oral Vaccine for Human Sales by Company (2018-2024) & (K Units)
Table 27. Global Oral Vaccine for Human Sales Share by Company (2018-2024)
Table 28. Global Oral Vaccine for Human Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Oral Vaccine for Human Revenue Share by Company (2018-2024)
Table 30. Global Market Oral Vaccine for Human Price by Company (2018-2024) & (US$/Unit)
Table 31. Global Oral Vaccine for Human Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Oral Vaccine for Human Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oral Vaccine for Human as of 2022)
Table 34. Date of Key Manufacturers Enter into Oral Vaccine for Human Market
Table 35. Key Manufacturers Oral Vaccine for Human Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Oral Vaccine for Human Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Global Oral Vaccine for Human Sales by Region (2018-2024) & (K Units)
Table 39. Global Oral Vaccine for Human Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Oral Vaccine for Human Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Oral Vaccine for Human Sales Market Share in Value by Region (2018-2024)
Table 42. Global Oral Vaccine for Human Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 43. Global Oral Vaccine for Human Sales by Region (2024-2029) & (K Units)
Table 44. Global Oral Vaccine for Human Sales Market Share in Volume by Region (2024-2029)
Table 45. Global Oral Vaccine for Human Sales by Region (2024-2029) & (US$ Million)
Table 46. Global Oral Vaccine for Human Sales Market Share in Value by Region (2024-2029)
Table 47. Global Oral Vaccine for Human Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 48. Global Oral Vaccine for Human Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 49. Global Oral Vaccine for Human Sales by Application (2018-2024) & (K Units)
Table 50. Global Oral Vaccine for Human Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Oral Vaccine for Human Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Oral Vaccine for Human Sales Market Share in Value by Application (2018-2024)
Table 53. Global Oral Vaccine for Human Price by Application (2018-2024) & (US$/Unit)
Table 54. Global Oral Vaccine for Human Sales by Application (2024-2029) & (K Units)
Table 55. Global Oral Vaccine for Human Sales Market Share in Volume by Application (2024-2029)
Table 56. Global Oral Vaccine for Human Sales by Application (2024-2029) & (US$ Million)
Table 57. Global Oral Vaccine for Human Sales Market Share in Value by Application (2024-2029)
Table 58. Global Oral Vaccine for Human Price by Application (2024-2029) & (US$/Unit)
Table 59. North America Oral Vaccine for Human Sales by Application (2018-2024) (K Units)
Table 60. North America Oral Vaccine for Human Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Oral Vaccine for Human Sales by Application (2018-2024) (K Units)
Table 62. Europe Oral Vaccine for Human Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Oral Vaccine for Human Sales by Application (2018-2024) (K Units)
Table 64. Asia-Pacific Oral Vaccine for Human Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Oral Vaccine for Human Sales by Application (2018-2024) (K Units)
Table 66. Latin America Oral Vaccine for Human Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Oral Vaccine for Human Sales by Application (2018-2024) (K Units)
Table 68. Middle East and Africa Oral Vaccine for Human Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Oral Vaccine for Human Sales by Country (2018-2024) & (K Units)
Table 70. North America Oral Vaccine for Human Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Oral Vaccine for Human Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Oral Vaccine for Human Sales Market Share in Value by Country (2018-2024)
Table 73. North America Oral Vaccine for Human Sales by Country (2024-2029) & (K Units)
Table 74. North America Oral Vaccine for Human Sales Market Share in Volume by Country (2024-2029)
Table 75. North America Oral Vaccine for Human Sales by Country (2024-2029) & (US$ Million)
Table 76. North America Oral Vaccine for Human Sales Market Share in Value by Country (2024-2029)
Table 77. Europe Oral Vaccine for Human Sales by Country (2018-2024) & (K Units)
Table 78. Europe Oral Vaccine for Human Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Oral Vaccine for Human Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Oral Vaccine for Human Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Oral Vaccine for Human Sales by Country (2024-2029) & (K Units)
Table 82. Europe Oral Vaccine for Human Sales Market Share in Volume by Country (2024-2029)
Table 83. Europe Oral Vaccine for Human Sales by Country (2024-2029) & (US$ Million)
Table 84. Europe Oral Vaccine for Human Sales Market Share in Value by Country (2024-2029)
Table 85. Asia-Pacific Oral Vaccine for Human Sales by Region (2018-2024) & (K Units)
Table 86. Asia-Pacific Oral Vaccine for Human Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Oral Vaccine for Human Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Oral Vaccine for Human Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Oral Vaccine for Human Sales by Region (2024-2029) & (K Units)
Table 90. Asia-Pacific Oral Vaccine for Human Sales Market Share in Volume by Region (2024-2029)
Table 91. Asia-Pacific Oral Vaccine for Human Sales by Region (2024-2029) & (US$ Million)
Table 92. Asia-Pacific Oral Vaccine for Human Sales Market Share in Value by Region (2024-2029)
Table 93. Latin America Oral Vaccine for Human Sales by Country (2018-2024) & (K Units)
Table 94. Latin America Oral Vaccine for Human Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Oral Vaccine for Human Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Oral Vaccine for Human Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Oral Vaccine for Human Sales by Country (2024-2029) & (K Units)
Table 98. Latin America Oral Vaccine for Human Sales Market Share in Volume by Country (2024-2029)
Table 99. Latin America Oral Vaccine for Human Sales by Country (2024-2029) & (US$ Million)
Table 100. Latin America Oral Vaccine for Human Sales Market Share in Value by Country (2024-2029)
Table 101. Middle East and Africa Oral Vaccine for Human Sales by Country (2018-2024) & (K Units)
Table 102. Middle East and Africa Oral Vaccine for Human Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Oral Vaccine for Human Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Oral Vaccine for Human Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Oral Vaccine for Human Sales by Country (2024-2029) & (K Units)
Table 106. Middle East and Africa Oral Vaccine for Human Sales Market Share in Volume by Country (2024-2029)
Table 107. Middle East and Africa Oral Vaccine for Human Sales by Country (2024-2029) & (US$ Million)
Table 108. Middle East and Africa Oral Vaccine for Human Sales Market Share in Value by Country (2024-2029)
Table 109. Merck Company Information
Table 110. Merck Introduction and Business Overview
Table 111. Merck Oral Vaccine for Human Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 112. Merck Oral Vaccine for Human Product
Table 113. Merck Recent Development
Table 114. GSK Company Information
Table 115. GSK Introduction and Business Overview
Table 116. GSK Oral Vaccine for Human Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 117. GSK Oral Vaccine for Human Product
Table 118. GSK Recent Development
Table 119. Sanofi Company Information
Table 120. Sanofi Introduction and Business Overview
Table 121. Sanofi Oral Vaccine for Human Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 122. Sanofi Oral Vaccine for Human Product
Table 123. Sanofi Recent Development
Table 124. Lanzhou Institute Company Information
Table 125. Lanzhou Institute Introduction and Business Overview
Table 126. Lanzhou Institute Oral Vaccine for Human Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 127. Lanzhou Institute Oral Vaccine for Human Product
Table 128. Lanzhou Institute Recent Development
Table 129. Serum Institute Company Information
Table 130. Serum Institute Introduction and Business Overview
Table 131. Serum Institute Oral Vaccine for Human Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 132. Serum Institute Oral Vaccine for Human Product
Table 133. Serum Institute Recent Development
Table 134. Valneva Company Information
Table 135. Valneva Introduction and Business Overview
Table 136. Valneva Oral Vaccine for Human Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 137. Valneva Oral Vaccine for Human Product
Table 138. Valneva Recent Development
Table 139. Shanghai United Cell Company Information
Table 140. Shanghai United Cell Introduction and Business Overview
Table 141. Shanghai United Cell Oral Vaccine for Human Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 142. Shanghai United Cell Oral Vaccine for Human Product
Table 143. Shanghai United Cell Recent Development
Table 144. Bibcol Company Information
Table 145. Bibcol Introduction and Business Overview
Table 146. Bibcol Oral Vaccine for Human Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 147. Bibcol Oral Vaccine for Human Product
Table 148. Bibcol Recent Development
Table 149. PaxVax Company Information
Table 150. PaxVax Introduction and Business Overview
Table 151. PaxVax Oral Vaccine for Human Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 152. PaxVax Oral Vaccine for Human Product
Table 153. PaxVax Recent Development
Table 154. Vabiotech Company Information
Table 155. Vabiotech Introduction and Business Overview
Table 156. Vabiotech Oral Vaccine for Human Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 157. Vabiotech Oral Vaccine for Human Product
Table 158. Vabiotech Recent Development
Table 159. Tiantan Biological Company Information
Table 160. Tiantan Biological Introduction and Business Overview
Table 161. Tiantan Biological Oral Vaccine for Human Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 162. Tiantan Biological Oral Vaccine for Human Product
Table 163. Tiantan Biological Recent Development
Table 164. EuBiologics Company Information
Table 165. EuBiologics Introduction and Business Overview
Table 166. EuBiologics Oral Vaccine for Human Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 167. EuBiologics Oral Vaccine for Human Product
Table 168. EuBiologics Recent Development
Table 169. Panacea Biotec Ltd Company Information
Table 170. Panacea Biotec Ltd Introduction and Business Overview
Table 171. Panacea Biotec Ltd Oral Vaccine for Human Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 172. Panacea Biotec Ltd Oral Vaccine for Human Product
Table 173. Panacea Biotec Ltd Recent Development
Table 174. Bio-Med Company Information
Table 175. Bio-Med Introduction and Business Overview
Table 176. Bio-Med Oral Vaccine for Human Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 177. Bio-Med Oral Vaccine for Human Product
Table 178. Bio-Med Recent Development
Table 179. Halfkin Bio-Pharmaceuticals Company Information
Table 180. Halfkin Bio-Pharmaceuticals Introduction and Business Overview
Table 181. Halfkin Bio-Pharmaceuticals Oral Vaccine for Human Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 182. Halfkin Bio-Pharmaceuticals Oral Vaccine for Human Product
Table 183. Halfkin Bio-Pharmaceuticals Recent Development
Table 184. Key Raw Materials Lists
Table 185. Raw Materials Key Suppliers Lists
Table 186. Oral Vaccine for Human Market Trends
Table 187. Oral Vaccine for Human Market Drivers
Table 188. Oral Vaccine for Human Market Challenges
Table 189. Oral Vaccine for Human Market Restraints
Table 190. Oral Vaccine for Human Distributors List
Table 191. Oral Vaccine for Human Downstream Customers
Table 192. Research Programs/Design for This Report
Table 193. Key Data Information from Secondary Sources
Table 194. Key Data Information from Primary Sources
List of Figures
Figure 1. Oral Vaccine for Human Product Picture
Figure 2. Global Oral Vaccine for Human Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Oral Vaccine for Human Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Oral Vaccine for Human Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Rotavirus Vaccine
Figure 6. Global Rotavirus Vaccine Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Cholera Vaccine
Figure 8. Global Cholera Vaccine Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of Oral Polio Vaccine
Figure 10. Global Oral Polio Vaccine Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Product Picture of Other
Figure 12. Global Other Sales YoY Growth (2018-2029) & (K Units)
Figure 13. Global Oral Vaccine for Human Sales by Type (2018-2029) & (US$ Million)
Figure 14. Global Oral Vaccine for Human Sales Market Share by Type in 2022 & 2029
Figure 15. North America Oral Vaccine for Human Sales Market Share in Volume by Type in 2022
Figure 16. North America Oral Vaccine for Human Sales Market Share in Value by Type in 2022
Figure 17. Europe Oral Vaccine for Human Sales Market Share in Volume by Type in 2022
Figure 18. Europe Oral Vaccine for Human Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Oral Vaccine for Human Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Oral Vaccine for Human Sales Market Share in Value by Type in 2022
Figure 21. Latin America Oral Vaccine for Human Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Oral Vaccine for Human Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Oral Vaccine for Human Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Oral Vaccine for Human Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Oral Vaccine for Human Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Oral Vaccine for Human Revenue in 2022
Figure 27. Oral Vaccine for Human Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Public
Figure 29. Global Public Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Product Picture of Private
Figure 31. Global Private Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Global Oral Vaccine for Human Sales by Application (2018-2029) & (US$ Million)
Figure 33. Global Oral Vaccine for Human Sales Market Share by Application in 2022 & 2029
Figure 34. North America Oral Vaccine for Human Sales Market Share in Volume by Application in 2022
Figure 35. North America Oral Vaccine for Human Sales Market Share in Value by Application in 2022
Figure 36. Europe Oral Vaccine for Human Sales Market Share in Volume by Application in 2022
Figure 37. Europe Oral Vaccine for Human Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Oral Vaccine for Human Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Oral Vaccine for Human Sales Market Share in Value by Application in 2022
Figure 40. Latin America Oral Vaccine for Human Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Oral Vaccine for Human Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Oral Vaccine for Human Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Oral Vaccine for Human Manufacturing Cost Structure
Figure 45. Oral Vaccine for Human Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries